Ergo Science Corp
OTC:ERGN
Ergo Science Corp
OTC:ERGN
Price:
10 800 USD
Market Closed
Updated:
Apr 28, 2024
P/S
Price to Sales
Price to Sales
2 160.3
Current
2 160.3
Median
2.3
Industry
Higher
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=2 160.3
Market Cap
/
55.2B
Revenue
25.6m
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| US |
|
Ergo Science Corp
OTC:ERGN
|
55.2B USD | 2 160.3 | |
| CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
540.8B CAD | 0 | |
| US |
V
|
Viveon Health Acquisition Corp
NYSE-MKT:VHAQ
|
332.4B USD | 0 | |
| US |
G
|
Gould Investors LP
OTC:GDVTZ
|
304.4B USD | 0 | |
| US |
C
|
Carson Energy Development Corp
OTC:CDVM
|
270.6B USD | 263 524.8 | |
| IN |
S
|
SAB Industries Ltd
BSE:539112
|
2.9B INR | 12 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
77.1B Zac | 0 | |
| US |
|
Liberty Bancshares Inc
OTC:LBSI
|
55.5B USD | 0 | |
| US |
H
|
HK Graphene Technology Corp
OTC:HKGT
|
53.9B USD | 0 | |
| ID |
|
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
692.5T IDR | 15.1 | |
| US |
|
Coupang Inc
F:788
|
38.4B EUR | 1.7 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
N/A
2-Years Forward
P/S
N/A
3-Years Forward
P/S
N/A
You don't have any saved screeners yet
